GLP1R and type 2 diabetes mellitus: Treatment with GLP-1 receptor agonists is also recommended as a first option in patients with T2DM at onset, especially in those at risk of cardiovascular disease, due to an important effect on both the primary and secondary prevention of ischemic disease [30].